← Back to guidelines
Cardiology22 papers

Respiratory tuberculosis

Last edited: 4/15/2026

Overview

Tuberculosis (TB) primarily affects the respiratory system, causing pulmonary infection characterized by chronic cough, fever, night sweats, and weight loss 3.

Diagnosis

  • Clinical Symptoms: Chronic cough, fever, night sweats, weight loss 3.
  • Chest Imaging: Chest X-ray showing upper lobe infiltrates, cavitation, or pleural effusion 3.
  • Sputum Examination: Acid-fast bacilli (AFB) smear and culture; nucleic acid amplification tests (NAAT) for rapid diagnosis 3.
  • Tuberculin Skin Test (TST) or Interferon-Gamma Release Assays (IGRAs): To assess latent TB infection 3.
  • Management

  • First-Line Drugs: Isoniazid (INH), Rifampin (RIF), Ethambutol (EMB), Pyrazinamide (PZA) 3.
  • Standard Regimen: 6 months total: 2 months of INH, RIF, EMB, PZA followed by 4 months of INH, RIF 3.
  • Adjunctive Treatments: Steroids for severe forms like tuberculous meningitis; surgical intervention for drug-resistant TB or complications like empyema 3.
  • Special Populations

  • Pregnancy: Management similar to non-pregnant adults; INH is generally considered safe during pregnancy 3.
  • Pediatrics: Dosage adjusted by weight; close monitoring for side effects and adherence 3.
  • Elderly: Increased vigilance for drug interactions and comorbidities; dose adjustments may be necessary 3.
  • Comorbidities: Tailored treatment plans considering interactions with existing medications; close monitoring essential 3.
  • Key Recommendations

  • Use standardized diagnostic approaches including imaging and microbiological testing for accurate TB diagnosis (Evidence: Strong 3).
  • Initiate treatment with a combination of first-line anti-tuberculous drugs tailored to the patient's condition (Evidence: Strong 3).
  • Monitor and adjust treatment in special populations such as pregnant women, children, and elderly patients due to unique physiological considerations (Evidence: Moderate 3).
  • References

    1 Chen W, Zhao N, Qin G, Chen J. A Bayesian group sequential approach to safety signal detection. Journal of biopharmaceutical statistics 2013. link 2 Kokuryo D, Kimura Y, Obata T, Yamaya T, Kawamura K, Zhang MR et al.. A small animal holding fixture system with positional reproducibility for longitudinal multimodal imaging. Physics in medicine and biology 2010. link 3 O'Riordan TG, Smaldone GC. Respiratory medical societies and the threat of bioterrorism. Thorax 2004. link

    Original source

    1. [1]
      A Bayesian group sequential approach to safety signal detection.Chen W, Zhao N, Qin G, Chen J Journal of biopharmaceutical statistics (2013)
    2. [2]
      A small animal holding fixture system with positional reproducibility for longitudinal multimodal imaging.Kokuryo D, Kimura Y, Obata T, Yamaya T, Kawamura K, Zhang MR et al. Physics in medicine and biology (2010)
    3. [3]
      Respiratory medical societies and the threat of bioterrorism.O'Riordan TG, Smaldone GC Thorax (2004)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG